S. ÖZLER And P. PAZARCI, "Anti-tumoral effect of beta-blockers on prostate and bladder cancer cells via mitogen-activated protein kinase pathways," ANTI-CANCER DRUGS , vol.33, no.4, pp.384-388, 2022
ÖZLER, S. And PAZARCI, P. 2022. Anti-tumoral effect of beta-blockers on prostate and bladder cancer cells via mitogen-activated protein kinase pathways. ANTI-CANCER DRUGS , vol.33, no.4 , 384-388.
ÖZLER, S., & PAZARCI, P., (2022). Anti-tumoral effect of beta-blockers on prostate and bladder cancer cells via mitogen-activated protein kinase pathways. ANTI-CANCER DRUGS , vol.33, no.4, 384-388.
ÖZLER, SERKAN, And PERÇİN PAZARCI. "Anti-tumoral effect of beta-blockers on prostate and bladder cancer cells via mitogen-activated protein kinase pathways," ANTI-CANCER DRUGS , vol.33, no.4, 384-388, 2022
ÖZLER, SERKAN And PAZARCI, PERÇİN. "Anti-tumoral effect of beta-blockers on prostate and bladder cancer cells via mitogen-activated protein kinase pathways." ANTI-CANCER DRUGS , vol.33, no.4, pp.384-388, 2022
ÖZLER, S. And PAZARCI, P. (2022) . "Anti-tumoral effect of beta-blockers on prostate and bladder cancer cells via mitogen-activated protein kinase pathways." ANTI-CANCER DRUGS , vol.33, no.4, pp.384-388.
@article{article, author={SERKAN ÖZLER And author={PERÇİN PAZARCI}, title={Anti-tumoral effect of beta-blockers on prostate and bladder cancer cells via mitogen-activated protein kinase pathways}, journal={ANTI-CANCER DRUGS}, year=2022, pages={384-388} }